​​​​​​​​​Current ​MEG Announcements

AACR-CSCO Young Investigator Awards 2019

The AACR in partnership with the Chinese Society for Clinical Oncology (CSCO) is providing travel awards to the CSCO Annual Meeting in Xiamen, China in September 2019. Please see here for further details. This Award includes complimentary registration to the CSCO Annual Meeting; accommodations for up to four nights; and $1,000 USD for travel expenses.
Application Deadline: July 19, 2019.

AACR Awards 2020 Nominations Now Being Accepted

All MEG members are encouraged to submit nominations for the 2020 AACR Awards, to include the AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention, and an inaugural award for 2020, the AACR Award for Outstanding Achievement in Basic Cancer Research that is intended for an early-career investigator. The deadline for nominations is Aug. 1, 2019. The deadline for nominations for the AACR June L. Biedler Prize for Cancer Journalism will remain sometime in November 2019. Details on this Award's nomination process will be forthcoming.

It was great to see so many MEG members and those from other fields of cancer research at the AACR Annual Meeting 2019 in Atlanta, Georgia! View webcasts from this major event. We look forward to seeing many of you at next year's Annual Meeting in San Diego, California, April 24-29, 2020.

Congratulations to the 2019 MEG Scholar-in-Training Awardees

Best wishes for continued success to our 2019 MEG Scholar-in-Training Award recipients Drs. Xiang Shu; Audrey Jung; and Konrad Stopsack! Their awards (known as 'SITAs') were presented during the AACR Annual Meeting 2019. Learn more about this award and this year's awardees. MEG members, did you know that the MEG annual membership dues help to support these three awards to allow early-career researchers to participate in the AACR Annual Meeting each year? Thank you for your continued support to early-career scientists.

Be sure to see the AACR blog: Cancer Research Catalyst!

See current information on scientific research and events in the AACR's blog Cancer Research Catalyst and how you can submit content!

Request for Proposals for Genome-wide Investigation of Late-effects Using the Childhood Cancer Survivor Study (CCSS) Cohort

The Childhood Cancer Survivor Study (CCSS) is an NCI-funded resource for the study of long-term survivors of cancer diagnosed during childhood and adolescence. Learn the details regarding the cohort.

Members of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute and CCSS investigators collaborated to conduct a genome-wide association study, initially intended to study the role of genetic susceptibility in the development of subsequent neoplasms as well as first primary childhood cancers using samples from the CCSS Biorepository. Genotyping was conducted for 5739 childhood cancer survivors diagnosed 1970-1986 (5324 are of European ancestry) using the Illumina HumanOmni5Exome microarray, with over 4.1 million loci passing quality control thresholds (based on locus and sample missing rates, sample heterozygosity, and sex discrepancies).
The CCSS leadership is now broadening the scope of this initiative to study the role of genetic susceptibility in the development of non-malignant, treatment-related outcomes in cancer survivors. Accordingly, CCSS is announcing a request for proposals to collaborate with CCSS and NCI investigators in the use of existing genome-wide association study (GWAS) data and corresponding outcomes-related data to address innovative research questions relating to potential genetic contributions to risk for non-malignant treatment-related outcomes. Requests will be accepted on an ongoing basis and will be reviewed three times per year, in February, June, and October (cut-off for receipt of applications February 1, June 1, October 1). 
Learn more details regarding the application process as well as the application for data access.

From the Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute

​The Epidemiology and Genomics Research Program in NCI’s Division of Cancer Control and Population Sciences invites AACR-MEG members to register for upcoming webinars.To learn more about the EGRP's webinar series, visit the SeqSPACE Upcoming Topics and Speakers webpage.

MEG Members Receive an Additional 5 Percent Discount on CEBP Accepted Manuscripts

MEG members receive a special 5 percent discount for publication fees only (not AuthorChoice) for articles accepted in Cancer Epidemiology, Biomarkers & Prevention (CEBP). This is in addition to the 5 percent discount given to all AACR members. Thus, MEG members receive a total discount of 10 percent. Just use the code "MEGAO2019" when receiving notification from the CEBP staff about author billing. See the information for authors for CEBP submissions. We look forward to receiving your submission.

CancerCareers Discounts Available

Be sure to check out for career opportunities. MEG members now receive a 15 percent discount for all employment postings. Use the code MEGAD when submitting your advertisement to receive this special rate. You can also sign-up for job alerts and refine a job search by a specific research area, i.e. epidemiology; prevention. Look on the right side of the website for these options.

To submit an announcement for consideration, please note:

Employment opportunities should be sent to for posting consideration on that website. Please refer all questions regarding employment posting to

Postings of a non-employment nature may still be sent to for review and possible future posting on the MEG Announcements.

Best regards from everyone at the AACR, and sincere appreciation for your
AACR-MEG Membership.